Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Volume
75
Pagination
1255 - 1264
DOI
10.1158/0008-5472.CAN-14-1801
Journal
CANCER RESEARCH
Issue
7
ISSN
0008-5472
Metadata
Show full item record
Authors
Milagrel, CS; Gopinathanl, G; Everitt, G; Thompson, RG; Kulbel, H; Zhong, H; Hollingsworth, RE; Grose, R; Bowte, DDL; Hochhauserzl, D
URI
http://qmro.qmul.ac.uk/jspui/handle/123456789/7203
Collections